AO Santa Maria della Misericordia

Perugia, Umbria 6132

1 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Chronic Lymphocytic Leukemia (CLL), Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Non-Small-Cell Lung

Studies at this site

• A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion — Recruiting now
• A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation — Completed
• Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer — Completed